The global biomanufacturing capacity gap and budget constraints have ignited the“The Fourth Revolutionary Wave of Biologics Manufacturing”, with production sites expanding towards million-liter scales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results